Search
for
Sort by
Research 601–630 of 1000+
- Clinical aspects of the metabolic syndrome
- Extensive alopecia areata: A multicenter review of 132 patients
- Presence of Codes for Indication for Use in Clinical Practice Research Datalink Aurum: An Assessment of Benign Prostatic Hyperplasia Treatments
- EXPLORING THE ROLE OF UMBILICAL CORD AND CORD BLOOD IN REGENERATIVE MEDICINE
- Comparative analysis of the use of complementary and alternative medicine by Korean patients with androgenetic alopecia, atopic dermatitis and psoriasis
- Cardiac tamponade due to minoxidil use: a case report and review of the literature
- Seborrhoeic Dermatitis in Pigmy Goats
- A Comprehensive Literature Review of JAK Inhibitors in Treatment of Alopecia Areata
- Fibroblasts in Diabetic Foot Ulcers
- Survey on Alopecia Areata Patients’ Reported Factors that Determine Severity of Alopecia Areata: A Nationwide Multicenter Study
- Vitamin D and aging
- Let astaxanthin be thy medicine
- Swellable Microneedles in Drug Delivery and Diagnostics
- Regenerative Medicine Therapy in Malaysia: An Update
- Adaptive Triboelectric Nanogenerators for Long-Term Self-Treatment: A Review
- Game Changers: Blockbuster Small-Molecule Drugs Approved by the FDA in 2024
- SALICYLATE INGESTION AND IDIOPATHIC HAIR LOSS
- Cytokine Engineering Approaches for Regenerative Medicine
- Combined Ultrasound and Microneedle for Enhanced Transdermal Delivery: Synergistic Mechanisms and Therapeutic Advances
- Wedelolactone: A Natural Anti-inflammatory Coumarin Derivative
- LIFEHOUSE’s Functional Nutrition Examination (Physical Exam, Anthropometrics, and Selected Biomarkers) Informs Personalized Wellness Interventions
- Health benefits attributed to 17α-estradiol, a lifespan-extending compound, are mediated through estrogen receptor α
- Grande symphonie funèbre et triomphale. H 80B
- Sport als Risikofaktor und therapeutisches Prinzip in der Dermatologie
- Bio-Nanovesicle-Based Approaches for Hair and Skin Regeneration: An Updated Concise Review
- Novel drugs of United States Food and Drug Administration approved in 2024
- PO:17:252 | The choice between belimumab and anifrolumab: analysis of a monocentric cohort
- PO:17:252 | The choice between belimumab and anifrolumab: analysis of a monocentric cohort
- Pharmacological evidences for the extracts and secondary metabolites from plants of the genus Hibiscus
- Preparation and Characterization of Ginger Peel Polysaccharide–Zn (II) Complexes and Evaluation of Anti-Inflammatory Activity